dichloroacetic acid has been researched along with B16 Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chaible, LM; da Fonseca, IIM; Dagli, MLZ; De Toledo, GF; Del-Grande, MP; do Nascimento, RS; Nagamine, MK; Tedardi, MV | 1 |
| Jiang, X; Kong, M; Qi, Y; Qin, X; Qin, Y; Shen, Y; Sun, Y; Wu, T; Yang, C; Zhang, Z | 1 |
| Huang, WD; Shen, SY; Zheng, MF | 1 |
3 other study(ies) available for dichloroacetic acid and B16 Melanoma
| Article | Year |
|---|---|
Sodium dichloroacetate attenuates the growth of B16-F10 melanoma in vitro and in vivo: an opportunity for drug repurposing.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dichloroacetic Acid; Dose-Response Relationship, Drug; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Skin Neoplasms; Tumor Burden | 2021 |
A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Diagnostic Imaging; Dichloroacetic Acid; Doxorubicin; Drug Delivery Systems; Endocytosis; Humans; Maximum Tolerated Dose; Melanoma, Experimental; Mice; Nanomedicine; Nanoparticles; Phosphatidylethanolamines; Polyethylene Glycols; Tissue Distribution | 2018 |
DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Deoxycytidine; Dichloroacetic Acid; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluorouracil; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Proteins; Prodrugs; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Random Allocation; Thymidine Phosphorylase; Xenograft Model Antitumor Assays | 2013 |